Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Deputy Editor
{5E322C17-98C6-494D-89ED-8827CF7BFB62}
+9 year(s) experience
Generics Bulletin
By David Wallace 14 Aug 2019
Chirag Patel and Chintu Patel have returned to being co-CEOs of Amneal, just over a year after the firm completed its merger with Impax. Rob Stewart – who was president and CEO of Amneal – and executive chairman Paul Bisaro have resigned from the roles.
Topic Company analysis
Generics Bulletin
By David Wallace 30 Jul 2019
As Sandoz reported its second-quarter financial results, the firm revealed details of a previously unannounced development program for biosimilar denosumab.
Topic Company analysis Biosimilars
Generics Bulletin
By David Wallace 07 Mar 2019
Two new categories – Value Added Medicine Of The Year and Legal Strategy Of The Year – have been added to the Global Generics & Biosimilars Awards in 2019, which will take place on 5 November in Frankfurt, Germany.
Topic BioPharmaceutical Biosimilars
Generics Bulletin
By David Wallace 07 Mar 2019
Several US senators have lent their backing to the draft Biologic Patent Transparency Act, as part of efforts to address “patent thickets” around brand biologics.
Pink Sheet
26 Jul 2019
In Vivo
03 Jul 2019
Scrip
16 May 2019
Pink Sheet
18 Apr 2019
In Vivo
20 Mar 2019
